RU2018121813A - Предварительно заполненный пластиковый шприц, содержащий антагонист vegf - Google Patents
Предварительно заполненный пластиковый шприц, содержащий антагонист vegf Download PDFInfo
- Publication number
- RU2018121813A RU2018121813A RU2018121813A RU2018121813A RU2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A RU 2018121813 A RU2018121813 A RU 2018121813A
- Authority
- RU
- Russia
- Prior art keywords
- filled syringe
- preceding paragraphs
- syringe according
- vegf antagonist
- liquid preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3286—Needle tip design, e.g. for improved penetration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M2005/3131—Syringe barrels specially adapted for improving sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Claims (16)
1. Предварительно заполненный шприц, содержащий жидкий препарат антагониста VEGF и имеющий корпус, выполненный из пластика, свободный от силикона и, кроме того, имеющий несъемный уплотнитель.
2. Предварительно заполненный шприц, содержащий жидкий препарат антагониста VEGF и имеющий корпус, выполненный из пластика, свободный от силикона и имеющий длину от 45 мм до 65 мм.
3. Предварительно заполненный шприц по п. 1 или 2, отличающийся тем, что антагонист VEGF представляет собой анти-VEGF антитело или антигенсвязывающий фрагмент такого антитела, или слитый белок рецептора VEGF.
4. Предварительно заполненный шприц по п. 3, отличающийся тем, что анти-VEGF антагонист представляет собой ранибизумаб или афлиберцепт.
5. Предварительно заполненный шприц по любому из предшествующих пунктов, отличающийся тем, что концентрация антагониста составляет 1-100 мг/мл.
6. Предварительно заполненный шприц по любому из предшествующих пунктов, содержащий менее 50 частиц, имеющих диаметр 10 мкм или более, на мл жидкого препарата.
7. Предварительно заполненный шприц по любому из предшествующих пунктов, содержащий менее 5 частиц, имеющих диаметр 25 мкм или более, на мл жидкого препарата.
8. Предварительно заполненный шприц по любому из предшествующих пунктов, характеризующийся силой трения скольжения, меньшей или равной 10 Н.
9. Предварительно заполненный шприц по любому из предшествующих пунктов, дополнительно имеющий свободный от силикона уплотнитель.
10. Предварительно заполненный шприц по любому из предшествующих пунктов, отличающийся тем, что корпус шприца выполнен из циклоолефинового полимера или циклоолефинового сополимера.
11. Предварительно заполненный шприц по любому из предшествующих пунктов, отличающийся тем, что корпус шприца имеет внутреннее покрытие, отличное от силиконового покрытия.
12. Предварительно заполненный шприц по любому из предшествующих пунктов, имеющий несъемную иглу.
13. Набор, включающий один или более предварительно заполненных шприцев по любому из предшествующих пунктов.
14. Предварительно заполненный шприц по любому из пп. 1-11 для применения в введении жидкого препарата антагониста VEGF пациенту, имеющему заболевание глаз.
15. Предварительно заполненный шприц для применения по п. 13 в случае, когда заболевание глаз выбирают из группы, состоящей из возрастной дегенерации желтого пятна (AMD), нарушения зрения вследствие диабетического отека желтого пятна (DME), нарушения зрения вследствие вторичного диабетического отека желтого пятна при окклюзии вен сетчатки (окклюзии ветвей центральной ВС или окклюзии центральной ВС), диабетической ретинопатии у пациентов с диабетическим отеком желтого пятна или нарушения зрения вследствие вторичной хориоидальной неоваскуляризации (CNV) при патологической миопии.
16. Предварительно заполненный шприц для применения по п. 14 или 15, при этом пациенту вводят жидкий препарат в объеме 30-100 мкл.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15195177.9 | 2015-11-18 | ||
EP15195177 | 2015-11-18 | ||
PCT/EP2016/078136 WO2017085253A1 (en) | 2015-11-18 | 2016-11-18 | Pre-filled plastic syringe containing a vegf antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2018121813A true RU2018121813A (ru) | 2019-12-19 |
RU2018121813A3 RU2018121813A3 (ru) | 2020-03-05 |
Family
ID=54608352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018121813A RU2018121813A (ru) | 2015-11-18 | 2016-11-18 | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf |
Country Status (12)
Country | Link |
---|---|
US (2) | US20180326126A1 (ru) |
EP (1) | EP3377151A1 (ru) |
JP (2) | JP2019501687A (ru) |
KR (1) | KR20180083377A (ru) |
CN (1) | CN108290004A (ru) |
AU (1) | AU2016356047B2 (ru) |
BR (1) | BR112018010005A2 (ru) |
CA (1) | CA3005692A1 (ru) |
MX (1) | MX2018006171A (ru) |
RU (1) | RU2018121813A (ru) |
WO (1) | WO2017085253A1 (ru) |
ZA (1) | ZA201802922B (ru) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
SG11201805420SA (en) | 2015-12-30 | 2018-07-30 | Kodiak Sciences Inc | Antibodies and conjugates thereof |
EP3407868A1 (en) | 2016-01-26 | 2018-12-05 | Formycon AG | Liquid formulation of a vegf antagonist |
CN111491680B (zh) | 2017-12-13 | 2023-08-29 | 里珍纳龙药品有限公司 | 用于精确剂量输送的装置和方法 |
WO2019136163A1 (en) | 2018-01-03 | 2019-07-11 | Irenix Medical, Inc. | Therapeutic agent delivery devices having integrated pain mitigation, and methods for using the same |
WO2019147944A1 (en) | 2018-01-26 | 2019-08-01 | The Regents Of The University Of California | Methods and compositions for treatment of angiogenic disordres using anti-vegf agents |
US11103552B2 (en) | 2018-05-10 | 2021-08-31 | Regeneron Pharmaceuticals, Inc. | High concentration VEGF receptor fusion protein containing formulations |
MA54052A (fr) * | 2018-10-29 | 2022-02-09 | Hoffmann La Roche | Formulation d'anticorps |
DK3659594T3 (da) * | 2018-11-30 | 2021-01-11 | Klaus Stegemann | Indgivelsessprøjte indeholdende en steril opløsning med et medicinsk aktivt stof og fremgangsmåde til fremstilling deraf |
JP2022535558A (ja) | 2019-06-05 | 2022-08-09 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 正確な容量送達のための装置 |
CN114786731A (zh) | 2019-10-10 | 2022-07-22 | 科达制药股份有限公司 | 治疗眼部病症的方法 |
KR20220104756A (ko) | 2019-11-25 | 2022-07-26 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 안구내 신생혈관형성을 위한 장기지속형 vegf 억제제 |
WO2021112925A1 (en) * | 2019-12-06 | 2021-06-10 | Regeneron Pharmaceuticals, Inc. | Anti-vegf protein compositions and methods for producing the same |
US20230226280A1 (en) * | 2020-09-25 | 2023-07-20 | Ocuject, Llc | Syringe injector with a feedback mechanism |
KR20220085906A (ko) * | 2020-12-15 | 2022-06-23 | 삼천당제약주식회사 | 안과용 제형을 포함하는 시린지 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3380450A (en) * | 1965-05-10 | 1968-04-30 | William H. Adelberger | Sterile disposable plastic prefilled syringe |
US6124449A (en) | 1990-06-11 | 2000-09-26 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
US5731424A (en) | 1990-06-11 | 1998-03-24 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands and inhibitors |
US5731144A (en) | 1990-06-11 | 1998-03-24 | Nexstar Pharmaceuticals, Inc. | High affinity TGFβ nucleic acid ligands |
US6582959B2 (en) | 1991-03-29 | 2003-06-24 | Genentech, Inc. | Antibodies to vascular endothelial cell growth factor |
DE69232539T3 (de) | 1992-10-28 | 2007-01-04 | Genentech, Inc., South San Francisco | Verwendung von anti-VEGF Antikörpern zur Behandlung von Krebs |
IL117645A (en) | 1995-03-30 | 2005-08-31 | Genentech Inc | Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration |
WO1996038579A1 (en) | 1995-06-02 | 1996-12-05 | Nexstar Pharmaceuticals, Inc. | High-affinity oligonucleotide ligands to growth factors |
SI1325932T1 (ru) | 1997-04-07 | 2005-08-31 | Genentech Inc | |
DE69841815D1 (de) | 1997-04-07 | 2010-09-16 | Genentech Inc | Anti-VEGF Antikörper |
US20020032315A1 (en) | 1997-08-06 | 2002-03-14 | Manuel Baca | Anti-vegf antibodies |
US6703020B1 (en) | 1999-04-28 | 2004-03-09 | Board Of Regents, The University Of Texas System | Antibody conjugate methods for selectively inhibiting VEGF |
CA2376379C (en) | 1999-06-08 | 2007-08-07 | Regeneron Pharmaceuticals, Inc. | Modified chimeric polypeptides with improved pharmacokinetic properties |
US7431989B2 (en) | 2003-05-06 | 2008-10-07 | Tribofilm Research, Inc. | Article with lubricated surface and method |
WO2005044853A2 (en) | 2003-11-01 | 2005-05-19 | Genentech, Inc. | Anti-vegf antibodies |
US20110060290A1 (en) * | 2008-02-07 | 2011-03-10 | Amgen Inc. | Stabilized protein compositions |
CN104961828B (zh) | 2008-06-25 | 2019-03-26 | 艾斯巴技术-诺华有限责任公司 | 抑制vegf的稳定和可溶的抗体 |
KR101698362B1 (ko) | 2008-11-03 | 2017-01-20 | 몰리큘라 파트너스 아게 | Vegf-a 수용체 상호작용을 억제하는 결합 단백질 |
US9597458B2 (en) * | 2009-10-29 | 2017-03-21 | W. L. Gore & Associates, Inc. | Fluoropolymer barrier materials for containers |
WO2011117878A1 (en) | 2010-03-20 | 2011-09-29 | Pawan Trilokchand Agrawal | Plastic pre-filled syringe |
AR081361A1 (es) | 2010-04-30 | 2012-08-29 | Molecular Partners Ag | Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a |
DE102011009057B4 (de) * | 2011-01-20 | 2015-12-10 | Schott Ag | Plasma-Behandlungsvorrichtung zur Herstellung von Beschichtungen und Verfahren zur innenseitigen Plasmabehandlung von Behältern |
JP6207401B2 (ja) * | 2012-01-31 | 2017-10-04 | テルモ株式会社 | プレフィルドシリンジ用シリンジ |
IN2014DN09689A (ru) * | 2012-06-01 | 2015-07-31 | Novartis Ag | |
JOP20200175A1 (ar) * | 2012-07-03 | 2017-06-16 | Novartis Ag | حقنة |
AU2012101678B4 (en) | 2012-07-03 | 2013-01-24 | Novartis Ag | Use of device |
JP2015528454A (ja) * | 2012-08-28 | 2015-09-28 | ノバルティス アーゲー | 眼血管増殖性疾患の処置におけるvegfアンタゴニストの使用 |
DE102013103676A1 (de) * | 2013-04-11 | 2014-10-30 | Schott Ag | Behälter mit geringer Partikelemission und reibkontrollierter Trockengleitoberfläche, sowie Verfahren zu dessen Herstellung |
MX2016000384A (es) * | 2013-07-11 | 2016-04-29 | Novartis Ag | Uso de un antagonista de vegf en el tratamiento de trastornos coriorretinianos neovasculares y de permeabilidad en pacientes pediatricos. |
AU2014332236B2 (en) * | 2013-10-07 | 2020-03-05 | Ocuject, Llc | Intraocular delivery devices and methods therefor |
EP3202389A4 (en) * | 2014-10-02 | 2018-06-20 | Terumo Kabushiki Kaisha | Medical container for accommodating protein solution preparation therein |
-
2016
- 2016-11-18 BR BR112018010005A patent/BR112018010005A2/pt not_active IP Right Cessation
- 2016-11-18 AU AU2016356047A patent/AU2016356047B2/en active Active
- 2016-11-18 MX MX2018006171A patent/MX2018006171A/es unknown
- 2016-11-18 WO PCT/EP2016/078136 patent/WO2017085253A1/en active Application Filing
- 2016-11-18 CN CN201680067304.7A patent/CN108290004A/zh active Pending
- 2016-11-18 JP JP2018525783A patent/JP2019501687A/ja active Pending
- 2016-11-18 US US15/776,418 patent/US20180326126A1/en not_active Abandoned
- 2016-11-18 EP EP16801743.2A patent/EP3377151A1/en active Pending
- 2016-11-18 CA CA3005692A patent/CA3005692A1/en active Pending
- 2016-11-18 RU RU2018121813A patent/RU2018121813A/ru unknown
- 2016-11-18 KR KR1020187016631A patent/KR20180083377A/ko unknown
-
2018
- 2018-05-04 ZA ZA2018/02922A patent/ZA201802922B/en unknown
-
2022
- 2022-07-18 US US17/867,098 patent/US20220362441A1/en active Pending
- 2022-09-12 JP JP2022144630A patent/JP2022177129A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA201802922B (en) | 2019-06-26 |
JP2019501687A (ja) | 2019-01-24 |
AU2016356047B2 (en) | 2021-10-21 |
WO2017085253A1 (en) | 2017-05-26 |
AU2016356047A1 (en) | 2018-05-24 |
US20220362441A1 (en) | 2022-11-17 |
CA3005692A1 (en) | 2017-05-26 |
BR112018010005A2 (pt) | 2018-11-21 |
RU2018121813A3 (ru) | 2020-03-05 |
KR20180083377A (ko) | 2018-07-20 |
CN108290004A (zh) | 2018-07-17 |
US20180326126A1 (en) | 2018-11-15 |
MX2018006171A (es) | 2018-12-19 |
JP2022177129A (ja) | 2022-11-30 |
EP3377151A1 (en) | 2018-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2018121813A (ru) | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf | |
RU2016148324A (ru) | Предварительно заполненный пластиковый шприц, содержащий антагонист vegf | |
JP2019501687A5 (ru) | ||
IL272913B1 (en) | A low volume pre-filled syringe is sterilized | |
TWI632920B (zh) | 注射器 | |
US20190351152A1 (en) | Autoinjector | |
JP2014087678A5 (ru) | ||
AU2016383061A1 (en) | Wearable automatic injection device and related methods of assembly and use | |
JP2018537170A5 (ja) | Vegf阻害薬の液体製剤を含んだプレフィルド薬剤シリンジ | |
CN105142695A (zh) | 身体轮廓可调适的自动注射器装置 | |
RU2020128686A (ru) | Анти-pvrig антитела и способы применения | |
EA201391812A1 (ru) | Отдельные вариабельные домены против vegf, слитые с fc-доменами | |
BR112015027385A2 (pt) | Anticorpos modificados de ligação ao fcrn humano e métodos de uso | |
CN106267189A (zh) | 含有抗白介素‑4 受体(il‑4r)的抗体的稳定制剂 | |
RU2019115610A (ru) | Антитела и полипептиды, направленные против cd127 | |
KR20220085906A (ko) | 안과용 제형을 포함하는 시린지 | |
Erichev et al. | Evaluating the efficacy of anti-VEGF therapy in patients with exudative age-related macular degeneration and concomitant glaucoma | |
MX2017003667A (es) | Jeringa pre-llenada de aplicacion oftalmica. | |
Forte et al. | Retinal Vein Occlusion Following Two Doses of mRNA-1237 (Moderna) Immunization for SARS-Cov-2: A Case Report | |
Cankaya | Acinetobacter baumannii endophthalmitis following intravitreal administration in an elderly patient: case report | |
Boyce | Sub-retinal haemorrhage: case report | |
CN110709104A (zh) | 用aplnr拮抗剂和vegf抑制剂治疗眼部病症的方法 | |
Nuzzi | Bevacizumab/pegaptanib |